Skip to main content
Erschienen in:

07.08.2024 | Original Article

Type 2 Usher Syndrome – A Cause for Sensorineural Hearing Loss

verfasst von: B.L.Yatish Kumar, Manjoo S. Reddy, N.Vijayendra Simha, K. Avinash

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Ausgabe 6/2024

Einloggen, um Zugang zu erhalten

Abstract

Usher syndrome is a genetic condition involving Sensorineural hearing loss and Retinitis pigmentosa (RP). Although considered a rare disease, it is the most frequent cause of deaf- blindness in humans. It is inherited in an autosomal recessive pattern. It is divided clinically into three significant groups: Type I, Type 2 and Type 3. A retrospective study was carried out for three patients over a period of 5 years in a medical college hospital presenting with non-progressive hearing loss and progressive diminished vision. History, complete ENT, audiological and ophthalmological evaluation was performed. 3 patients (2 males, 1 Female) with a mean age 24 years had bilateral moderate to severe sensorineural hearing loss and bilateral retinitis pigmentosa. All patients were rehabilitated with hearing aids, and medical treatment was given for ophthalmic issues. Usher syndrome is the rare possibility of bilateral hearing loss since early childhood. Early detection of this condition with audiological and ophthalmic examination will improve the quality of life, improve hearing and delay the progression of complete blindness.
Literatur
1.
Zurück zum Zitat Koenekoop R, Arriaga M, Trzupek KM, Lentz J, Usher Syndrome Type I (1999) In GeneReviews®; Adam, Ardinger MP, Pagon HH, Wallace RA, Bean SE, Mirzaa LJH, Amemiya G, A., (eds).; University of Washington: Seattle, WA, USA Koenekoop R, Arriaga M, Trzupek KM, Lentz J, Usher Syndrome Type I (1999) In GeneReviews®; Adam, Ardinger MP, Pagon HH, Wallace RA, Bean SE, Mirzaa LJH, Amemiya G, A., (eds).; University of Washington: Seattle, WA, USA
2.
Zurück zum Zitat Reiners J, Nagel-Wolfrum K, Jurgens K, Marker T, Wolfrum U (2006) Molecular basis of human Usher syndrome: deciphering the meshes of the usher protein network provides insights into the pathomechanisms of the Usher disease. Exp Eye Res 83:97–119CrossRefPubMed Reiners J, Nagel-Wolfrum K, Jurgens K, Marker T, Wolfrum U (2006) Molecular basis of human Usher syndrome: deciphering the meshes of the usher protein network provides insights into the pathomechanisms of the Usher disease. Exp Eye Res 83:97–119CrossRefPubMed
3.
Zurück zum Zitat Usher CH (1914) On the inheritance of Retinitis pigmentosa with notes of cases. R Lond Opthalmol Hosp Rep 19:130–236 Usher CH (1914) On the inheritance of Retinitis pigmentosa with notes of cases. R Lond Opthalmol Hosp Rep 19:130–236
4.
Zurück zum Zitat Castiglione A, Busi M, Martini A (2013) Syndromic hearing loss: an update. Hear Balance Commun 11:146–159CrossRef Castiglione A, Busi M, Martini A (2013) Syndromic hearing loss: an update. Hear Balance Commun 11:146–159CrossRef
5.
Zurück zum Zitat Busi M, Castiglione A, Masieri MT, Ravani A, Guaran V, Astolfi L, Trevisi P, Ferlini A, Martini A (2012) Novel mutations in the SLC26A4 gene. Int J Pediatr Otorhinolaryngol 76:1249–1254CrossRefPubMed Busi M, Castiglione A, Masieri MT, Ravani A, Guaran V, Astolfi L, Trevisi P, Ferlini A, Martini A (2012) Novel mutations in the SLC26A4 gene. Int J Pediatr Otorhinolaryngol 76:1249–1254CrossRefPubMed
6.
Zurück zum Zitat Castiglione A, Melchionda S, Carella M, Trevisi P, Bovo R, Manara R, Martini A (2014) EYA1- related disorders: two clinical cases and a literature review. Int J Pediatr Otorhinolaryngol 78:1201–1210CrossRefPubMed Castiglione A, Melchionda S, Carella M, Trevisi P, Bovo R, Manara R, Martini A (2014) EYA1- related disorders: two clinical cases and a literature review. Int J Pediatr Otorhinolaryngol 78:1201–1210CrossRefPubMed
7.
Zurück zum Zitat Smith RJH, Berlin CI et al (1994) Clinical diagnosis of Usher’s syndrome,Usher’s syndrome consortium. Am J Med Genet 50:32–38CrossRefPubMed Smith RJH, Berlin CI et al (1994) Clinical diagnosis of Usher’s syndrome,Usher’s syndrome consortium. Am J Med Genet 50:32–38CrossRefPubMed
8.
Zurück zum Zitat Fishman GA, Kumar A, Joseph ME et al (1983) Usher’s syndrome:Ophthalmic and neuro otologic findings suggesting genetic heterogeneity. Arch Ophthalmol 101:1367–1374CrossRefPubMed Fishman GA, Kumar A, Joseph ME et al (1983) Usher’s syndrome:Ophthalmic and neuro otologic findings suggesting genetic heterogeneity. Arch Ophthalmol 101:1367–1374CrossRefPubMed
9.
Zurück zum Zitat Koenekoop R, Arriaga M, Trzupek KM et al (1993) Usher Syndrome Type II. 1999 Dec 10 [Updated 2023 Mar 23]. In: Adam MP, Feldman J, Mirzaa GM, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; –2024 Koenekoop R, Arriaga M, Trzupek KM et al (1993) Usher Syndrome Type II. 1999 Dec 10 [Updated 2023 Mar 23]. In: Adam MP, Feldman J, Mirzaa GM, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; –2024
10.
Zurück zum Zitat Connor WE, De ,Welberg C (1997) Etal. Sperm abnormalities in Retinitis Pigmentosa. Invest Ophthalmol Vis Sci 38:2619–2626PubMed Connor WE, De ,Welberg C (1997) Etal. Sperm abnormalities in Retinitis Pigmentosa. Invest Ophthalmol Vis Sci 38:2619–2626PubMed
11.
Zurück zum Zitat Tsilou B, Rubin et al (2002) Usher syndrome clinical types I and II: could ocular symptoms and signs differentiate between the two types? Acta Ophthalmol Scand 80:196–201CrossRefPubMed Tsilou B, Rubin et al (2002) Usher syndrome clinical types I and II: could ocular symptoms and signs differentiate between the two types? Acta Ophthalmol Scand 80:196–201CrossRefPubMed
12.
Zurück zum Zitat Eudy JD, Weston MD, Yao SF et al (1998) Mutation of a gene encoding a protein with extracellular matrix motifs in USH2A. Science 28:1753–1757CrossRef Eudy JD, Weston MD, Yao SF et al (1998) Mutation of a gene encoding a protein with extracellular matrix motifs in USH2A. Science 28:1753–1757CrossRef
15.
Zurück zum Zitat Retinitis pigmentosa (2018) Recent advances and future directions in diagnosis and management. Fahim A. Curr Opin Pediatr 30:725–733CrossRef Retinitis pigmentosa (2018) Recent advances and future directions in diagnosis and management. Fahim A. Curr Opin Pediatr 30:725–733CrossRef
16.
Zurück zum Zitat Davies C, Bergman J, Misztal C, Ramchandran R, Mittal J, Bulut E, Shah V, Mittal R, Eshraghi AA The outcomes of Cochlear Implantation in Usher Syndrome: a systematic review. J Clin Med 2021 Jun 29;10(13):2915. https://doi.org/10.3390/jcm10132915. PMID: 34209904; PMCID: PMC8267700. Davies C, Bergman J, Misztal C, Ramchandran R, Mittal J, Bulut E, Shah V, Mittal R, Eshraghi AA The outcomes of Cochlear Implantation in Usher Syndrome: a systematic review. J Clin Med 2021 Jun 29;10(13):2915. https://​doi.​org/​10.​3390/​jcm10132915. PMID: 34209904; PMCID: PMC8267700.
17.
Zurück zum Zitat Berson EL, Rosner B, Sandberg MA et al (1993) A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 111:761–772CrossRefPubMed Berson EL, Rosner B, Sandberg MA et al (1993) A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 111:761–772CrossRefPubMed
18.
Zurück zum Zitat Aleman TS, Duncan JL, Bieber ML et al (2001) Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome. Investig Ophthalmol Vis Sci 42(8):1873–1881 PMID: 11431456 Aleman TS, Duncan JL, Bieber ML et al (2001) Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome. Investig Ophthalmol Vis Sci 42(8):1873–1881 PMID: 11431456
19.
Zurück zum Zitat Hoffman DR, Hughbanks-Wheaton DK, Spencer R, Fish GE, Pearson NS, Wang YZ, Klein M, Takacs A, Locke KG, Birch DG (2015 Oct) Docosahexaenoic acid slows visual field progression in X-Linked Retinitis Pigmentosa: ancillary outcomes of the DHAX Trial. Invest Ophthalmol Vis Sci 56(11):6646–6653. https://doi.org/10.1167/iovs.15-17786PMID: 26469750; PMCID: PMC5963311 Hoffman DR, Hughbanks-Wheaton DK, Spencer R, Fish GE, Pearson NS, Wang YZ, Klein M, Takacs A, Locke KG, Birch DG (2015 Oct) Docosahexaenoic acid slows visual field progression in X-Linked Retinitis Pigmentosa: ancillary outcomes of the DHAX Trial. Invest Ophthalmol Vis Sci 56(11):6646–6653. https://​doi.​org/​10.​1167/​iovs.​15-17786PMID: 26469750; PMCID: PMC5963311
Metadaten
Titel
Type 2 Usher Syndrome – A Cause for Sensorineural Hearing Loss
verfasst von
B.L.Yatish Kumar
Manjoo S. Reddy
N.Vijayendra Simha
K. Avinash
Publikationsdatum
07.08.2024
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe 6/2024
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-024-04953-9

Neu im Fachgebiet HNO

Riesenzellarteriitis: bilaterale Biopsie der Temporalarterien von Vorteil

Die Riesenzellarteriitis (RZA) erfordert eine rasche und präzise Diagnose, da innerhalb weniger Tage ein schwerer, irreversibler Sehverlust drohen kann. In diesem Zusammenhang scheint die bilaterale Biopsie der Temporalarterien (TAB) der unilateralen überlegen zu sein.

Lagerungsschwindel hält trotz Manöver an: Was steckt dahinter?

Ob sich ein benigner paroxysmaler Lagerungsschwindel erfolgreich behandeln lässt, könnte einem chinesischen Team zufolge auch von psychischen Faktoren abhängen.

Lärm führt zu schnellerem Hörverlust im Alter

Ergebnisse einer US-Kohortenstudie sprechen dafür, dass Menschen, die in ihrem Leben mehr Lärm ausgesetzt waren, im Alter stärker in bestimmten Frequenzbereichen an Hörvermögen einbüßen.

Kaffee und Tee können das Risiko für Kopf-Hals-Tumoren senken

Gute Nachrichten für Kaffee- und Teetrinker: Menschen, die die Heißgetränke regelmäßig zu sich nehmen, haben ein geringeres Risiko, an bestimmten Kopf-Hals-Tumoren zu erkranken.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.